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CompartmentalizationViral compartmentalization between naïve and memory CD4+ T cell subsets has been described, but only for
individuals who were receiving antiretroviral therapy (ART). We present here an extensive analysis of the
viral quasispecies residing in the naïve, central and effector memory CD4+ T cell subsets in a number of
therapy naïve individuals and representing an array of HIV-1 subtypes. We longitudinally analyzed subset-
speciﬁc infection and evolution in a subtype B infected individual who switches from CCR5 to dual CCR5/
CXCR4 coreceptor usage. We show that the central memory subset, the predominantly infected subset,
harbors a more diverse viral population compared to the others. Through sequence analysis of the env C2V3
region we demonstrate a lack of viral compartmentalization among all subsets. Upon coreceptor switch we
observe a pronounced increase in the infection level of the naïve population. Our ﬁndings emphasize the
importance of all CD4+ T cell subsets to viral evolution.
© 2009 Elsevier Inc. All rights reserved.Introduction
During human immunodeﬁciency virus type 1 (HIV-1) and simian
immunodeﬁciency virus (SIV) infection the memory CD4+ T cell
population in the gut-associated lymphoid tissue (GALT) is preferen-
tially and rapidly depleted (Mehandru et al., 2007; Veazey et al., 1998;
Veazey et al., 2000; Li et al., 2005; Brenchley et al., 2004b; Mattapallil
et al., 2005). This population must be replenished by naïve and/or
central memory cells in order tomaintain immune function at effector
sites (Lanzavecchia and Sallusto, 2005; Picker et al., 2004). This
replenishment also results in an increased presence of target cells in
the tissues fueling virus replication and immune activation. Due to the
continuous destruction of tissue effector memory cells, increasingly
more naïve and central memory cells need to repopulate the effector
memory subset (Younes et al., 2003; Hazenberg et al., 2000). This
phenomenon, in combinationwithmany other events, may eventuallyr, Meibergdreef 15, 1105 AZ
).
onal BV, Exportstraat 39B, P.O.
l rights reserved.lead to decreased replenishment (Douek et al., 2003). A reduction in
tissue delivery of the effector memory subset, in combination with
destruction of this decreasing subset will ultimately lead to disease
progression (Okoye et al., 2007).
HIV-1 populations isolated from various tissues have been shown
to differ in cell tropism, diversity and drug resistance phenotype
(Si-Mohamed et al., 2000; Venturi et al., 2000; Zhang et al., 2002). At
the cellular level compartmentalization has also been shown to exist
among CD4+ T cells, CD8+ T cells and cells of the monocytic lineage
(Delobel et al., 2005; Potter et al., 2006; Fulcher et al., 2004). Within
the variant CD4+ Tcell populations the naïve cells can be productively
infected with HIV-1 despite low levels of CCR5 expression. The
lymphoid tissue microenvironment and/or HIV-1 envelope signaling
may therefore overcome low CCR5 expression levels and result in
productive infection of this cell type (Zhang et al., 1999; Chanel et al.,
2002; Eckstein et al., 2001; Kinter et al., 2003). In addition, part of the
SIV-infected memory CD4+ T cell pool has no detectable CCR5
expression, although this might also be explained by down-regulation
of this coreceptor upon infection (Mattapallil et al., 2005). Different
CD4+ T cell subsets express variant levels of CCR5 with the effector
memory expressing higher levels than the central memory cells and
the naïve cells expressing low to undetectable levels of CCR5 (Groot
et al., 2006; Bleul et al., 1997). Besides differences in coreceptor
expression, variations in cell number, localization and proliferation
25E.J. Heeregrave et al. / Virology 393 (2009) 24–32stage will also presumably inﬂuence viral compartmentalization and
contribute to the characteristics of the viral quasispecies (Douek et al.,
2003; Lanzavecchia and Sallusto, 2005).
Various publications have studied the relationship between
coreceptor expression and compartmentalization among CD4+ T cell
subsets (van Rij et al., 2000). From in vitro experiments it is known
that CCR5 (R5) HIV-1 variants preferentially infect effector memory
CD4+ T cells, while CXCR4 (X4) variants are mainly found within the
central memory and/or naïve subset (Gondois-Rey et al., 2002; Grivel
et al., 2000; Blaak et al., 2000). Among two in vivo studies under the
inﬂuence of highly active antiretroviral therapy (HAART) treatment
there is no consensus on the presence of viral compartmentalization
between naïve and memory CD4+ T cells subsets, while comparable
coreceptor usage was observed (Delobel et al., 2005; Ostrowski et al.,
1999). A detailed in vivo analysis of the viral genotypes residing in the
naïve, central and effector memory CD4+ T cell subsets without the
inﬂuence of antiretroviral therapy (ART) is still lacking.
Viral diversity within the gp120 envelope gene (env) and
speciﬁcally within the C2V3 region has been previously linked to
disease progression (Carvajal-Rodriguez et al., 2008; Shankarappa
et al., 1999). The variable V3 loop of the HIV-1 gp120 envelope,
together with the V1V2 region, has been extensively linked to core-
ceptor usage (Pollakis et al., 2001; Nabatov et al., 2004; Pastore et al.,
2007; Fouchier et al., 1992; Pollakis et al., 2004). Changes in amino
acid composition, length, V3 charge as well as glycosylation patterns
of these regions can inﬂuence coreceptor usage and therefore likely
inﬂuence the cell type of infection.
HIV-1 infection levels of CD4+ T cell subsets (including naïve,
central memory and effector memory cells) have previously been
monitored for a group of North-American individuals, presumably
infected with HIV-1 subtype B (Brenchley et al., 2004a). We followed
up on these results to examine the viral quasispecies residing in each of
these subsets through env C2V3 sequence analysis in 13 patients
without the inﬂuence of ART. Additionally, we studied HIV-1 infection
levels and analyzed subset-speciﬁc viral evolution. Despite large
variation in subset infection levels, we do not detect HIV-1 compart-
mentalization among the various CD4+ T cell subsets and we observe
equal nucleotide distances. Upon coreceptor switch, the naïve subset
demonstrates a more pronounced increase in infection levels and
decrease of cell number as compared to the memory subsets, which
does not result in viral compartmentalization in this patient.Table 1
Patient description.
Patient Country of origin Gender Age at 1st
time-point
M13408 Tanzania F 32
M12817 Dom. Rep.a F 29
H671 Netherlands M 39
H434 Netherlands M 50
M11781 Zambia F 22
M16394 Netherlands F 34
M11306 Kenya M 34
M12003 Ethiopia M 36
M12020 D.R. Congo F 35
M12259 D.R. Congo M 50
M11814 D.R. Congo F 22
M12228 Liberia F 27
M12092 Suriname F 22
a Dom. Rep.: Dominican Republic.
b mpsc: months post seroconversion.
c n.a.: not available.
d Viral load data obtained on 15, 60 resp. 117 mpsc.Results
Large variation in CD4+ T cell subset infection levels
Here we analyzed HIV-1 compartmentalization among various
CD4+ T cell subsets in peripheral blood of thirteen ART-naïve HIV-1
infected individuals. For eleven out of thirteen individuals PBMC from
multiple time-points were available and studied. Table 1 shows the
patient characteristics of the ﬁrst time-point for all patients and all
time-points for patients H434 and H671. We included these two well-
characterized subtype B infected individuals for longitudinal analyses.
Since infection levels might inﬂuence compartmentalization, we
quantiﬁed HIV-1 infection in FACS-sorted naïve, CD57− and CD57+
memory CD4+ T cell subsets (supplemental data I).
Fig. 1 depicts the relative infection levels of eleven out of thirteen
patients tested. Infection levels were highly variable among the
cellular subsets. The CD57−memory subset was being predominantly
infected in seven out of eleven patients, in accordance with previous
ﬁndings (Brenchley et al., 2004a). In two individuals, the naïve and
CD57+memory subsets were predominantly infected. For eight out of
the eleven patients, where multiple time-points were available,
infection levels were consistent over time, up to three years for
patient M12259.
When absolute cellular infection levels were compared to
markers of disease progression, the naïve and CD57− memory
subsets showed a signiﬁcant inverse correlation with the CD4 count
(rs=−0.65 and pb0.01 for the naïve subset; rs=−0.57 and pb0.05
for the CD57− memory subset; data not shown). In addition, the
CD57− memory subset also signiﬁcantly correlated with the viral
load (rs=0.60; pb0.05; data not shown) indicating that infection of
speciﬁc CD4+ T cell subsets can be linked to markers of disease
progression. The infection levels of the CD57− memory subset also
correlated with those of the naïve and the CD57+ memory subset
(rs=0.50, pb0.05 and rs=0.78, pb0.0001 respectively; data not
shown). This conﬁrms previous data and indicates viral genome
exchange among the subsets or differentiation of one subset into
another (Brenchley et al., 2004a).
In summary, HIV-1 infection levels vary greatly among the
different cellular subsets, with naïve and CD57− memory infection
levels showing a signiﬁcant inverse correlation with CD4+ T cell
counts.env subtype Months after
1st visit
Viral load
(copies/ml)
CD4 count
(cells/μl)
A 32 65,262 620
B 5 n.a.c 640
B 0.2 mpscb 1000 1390
57 mpsc 22,000 770
69 mpsc 19,564 790
89 mpsc 37,191 400
B 18 mpsc 20,000d 610
57 mpsc 27,000d 580
124 mpsc 515,000d 290
C 0 6060 460
C 38 1026 800
C 5 58,711 350
C 27 4538 n.a.
D 3 1059 430
F 9 100,630 870
F 9 129,442 n.a.
G 5 47,149 300
G 4 14,180 300
Fig. 1. Cellular infection levels. Each pie chart shows the relative infection levels of the
naïve, CD57− memory and CD57+ memory subsets. For each patient, the relative
number of LTR copies per 105 cells of one time-point is shown. For patients M11781 and
M16394 infection levels for all subsets could not be determined.
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To study whether differences in infection levels inﬂuenced
compartmentalization among the various CD4+ T cell subsets, we
ampliﬁed the env C2V3 region from each subset as well as from serum.Fig. 2. Neighbor-joining phylogenetic trees of patient M11814 9, 24 and 31 months after pr
represented by different symbols, as depicted in the legend. Reference strains are marked by
replicates, only bootstrap values higher than 80% are shown and the Kimura-2 parameter wBased on phylogenetic analysis we identify no compartmentalization
among the different cellular subsets or serum in twelve out of thirteen
patients studied over time (Fig. 2 and supplemental data II). Fig. 2
shows a representative phylogenetic analysis of three different time-
points for patient M11814, with intermingling sequences from the
various subsets identiﬁed. For all patients, this image was consistent
when longitudinal samples were analyzed (data not shown). In
addition, in patients H671 and H434 we observed comparable evo-
lutionary rates among all cellular subsets and serum (M. Geels,
unpublished results). Analysis of the viral sequences from patient
M12817 demonstrated compartmentalization among the different
cellular subsets for some but not all time-points. Unfortunately, serum
samples of this patient were unavailable for analysis.
To conﬁrm the ﬁndings of our phylogenetic analyses, we next
calculated genetic distances between all subsets (Fig. 3). We found no
signiﬁcant differences among any of these comparisons conﬁrming the
lack of compartmentalization. Median nucleotide distances varied
between 4.3% for CM vs. EM and 4.9% for N vs. EM, N vs. S and EM vs. S.
Synonymous nucleotide distances (dS) ranged from 2.2 to 2.8% and non-
synonymous nucleotide distances (dN) from 3.7 to 4.7% with no
signiﬁcantdifferences found forany tested comparisons (datanot shown).
We also determined the viral diversity within each subset
(Table 2). When analyzing the synonymous nucleotide distances, all
subsets harbored comparable levels of diversity with no signiﬁcant
differences, although the CD57+ memory subset contained the least
diverse viral population (median value of 1.4%). For the non-imary diagnosis. Env C2V3 sequences from the various cellular subsets and serum are
diamonds and are shown at the bottom of each tree. For these bootstrap trees of 1000
as used to calculate nucleotide distances.
Fig. 3. Nucleotide distances among all subset comparisons. The horizontal bar depicts
median values. N — Naïve; CM — CD57− memory; EM — CD57+ memory; S — Serum.
Fig. 4. Coreceptor usage of R5X4 clones from patient H671, 85 and 89 mpsc. U87.CD4
cells expressing either CCR5 or CXCR4 were infected with H671 R5X4 biological clones
to determine coreceptor usage. Read-out was CA-p24 levels (ng/ml) in culture
supernatant after seven days.
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signiﬁcantly more diverse collection of viral sequences over the
other subsets (a median value of 3.8%; pb0.05). Besides alterations in
nucleotide distance the genetic sequences were also analyzed for
alterations in dN/dS ratios andG toAhyper-mutation levels, a potential
indication of APOBEC3G/F activity (Mangeat et al., 2003). For both
parameters variable levels were observed within the different subsets
but with no clear patterns, indicating lack of cellular subset-speciﬁc
evolutionary pressures on the virus.
In conclusion, despite the observation that the CD57− memory
subset demonstrates the highest level of infection and diversity, we
ﬁnd no evidence of compartmentalization between the variant CD4+
cellular subsets analyzed and observe similar genetic distances of viral
sequences among all subset comparisons.
Subset-speciﬁc infection and evolution
In two well-characterized HIV-1 seroconverters, patients H671 and
H434 (Geels et al., 2003, 2006), we longitudinally studied compart-
mentalization along with subset-speciﬁc infection and evolution. We
had previously reported that patient H671 underwent a switch from a
non-syncytium inducing (NSI) to a syncytium inducing (SI) phenotype
between 57 and 69months post seroconversion (mpsc), while the viral
phenotype of patient H434 remained NSI throughout follow-up.
Replication competent biological clones (RCBCs) were generated from
PBMC and coreceptor usage was determined (Geels et al., 2006, 2003).
All generated biological clones frompatient H434 utilized only the CCR5
coreceptor on U87.CD4 cells, whilst the later RCBCs from patient H671
at 85 and 89mpsc could utilize both U87.CD4 cells expressing CCR5 and
CXCR4 (Fig. 4). This was conﬁrmed by infection of CD4+ lymphocytes
isolated from individuals homozygous for the 32 bp deletion in the
CCR5 gene (de Roda Husman et al., 1999; Liu et al., 1996).
We longitudinally determined cellular infection levels of the three
CD4+ T cell subsets in the peripheral blood of H671 and H434. The
CD57− memory CD4+ T cell subset was the predominantly infected
subset during the respective R5 stages of infection in both patients
(Figs. 5A and B). Interestingly, we detected early infection of the naïve
cells albeit at very low levels (3.9 vs. 14.4 copies per 105 sorted cells
respectively; Figs. 5A and B). Infection levels of all subsets increasedTable 2
Viral diversity within each subset.
Subset Synonymous diversitya Non-synonymous diversity
Naïve 2.3 (0.2–4.6) 3.4 (0.2–9.0)
CD57− memory 2.4 (0.0–5.1) 3.8 (0.1–9.2)b
CD57+ memory 1.4 (0.0–6.3) 2.4 (0.1–10.1)
Serum 2.0 (0.2–5.0) 3.4 (0.1–8.9)
a Values are in percentage and represent median values of all time-points studied; no
signiﬁcant differences between the subsets.
b The CD57− memory subset was signiﬁcantly more diverse than all other subsets
(pb0.05).over time, except for the CD57+memory subset of H671. We observed
a dramatic increase in the infection level of naïve cells for patient
H671 at 69 mpsc, when R5X4 viruses ﬁrst emerged. At 89 mpsc, the
naïve subset was the predominant infected cell population in this
patient (Fig. 5B). Following an increase in the infection level of the
naïve population there was a 38.9 fold reduction in this cell
population, resulting in seven cells per μl at 89 mpsc (Fig. 5D).
Changes for the CD57− memory subset were more modest (Figs. 5C
and D). Absolute cell numbers of the CD57+memory subset remained
consistent for both patients, despite an increase in infection over time
for H434. Surprisingly, phylogenetic analyses of both individuals
demonstrated lack of compartmentalization at all time-points, despite
the coreceptor switch of patient H671 (M. Geels, unpublished results).
These observations suggest that in these two individuals a
different pattern of subset infection and evolution, partly due to
coreceptor switch, did not result in viral compartmentalization.
Distribution of HIV-1 genotypes among CD4+ T cell subsets
To correlate CD4+ Tcell subset infection levelswith the viral genotype
within each of the different subsets and relate this to the viral variants
present in the sera, we analyzed the env V3 chargewithin the three CD4+
T cell subsets, serum and RCBCs of patients H671 and H434. A higher V3
charge has been heavily associated with a switch in coreceptor usage
towards CXCR4 utilization (Nabatov et al., 2004; Fouchier et al., 1992). All
subsets showacomparable increase inV3chargeover time(Fig. 6).During
the R5 stages of infection of both patients, all CD4+ T cell compartments
harbored viruses that largely possess an R5-signature. After the switch in
coreceptor usage for H671 at 69 mpsc, the higher charged viruses
preferentially infected the naïve and CD57− memory subsets, while the
CD57+ memory subset harbored the lower charged variants. This
distribution did not lead to compartmentalization in our phylogenetic
analyses (M. Geels, unpublished data). At 89 mpsc, the V3 charge of the
viral variants among the different subsets showed equal distribution
again, with +5 charged viruses dominating every subset. Coreceptor
usage predictions by PSSM conﬁrmed these ﬁndings. Throughout the
entire follow-up (except for 69mpsc of patient H671), viruses possessing
similar V3 charges were isolated from all the different cellular compart-
ments. These results indicate no compartmentalization with respect to
molecular determinants associatedwith different HIV-1 coreceptor usage
patterns in either the switching or the non-switching patient.
Discussion
Here we examined HIV-1 infection in various CD4+ T cell subsets
in vivo. Our phylogenetic analysis and the observation of equal
nucleotide distances of the viral quasispecies among naïve, central
Fig. 5. Longitudinal analysis of HIV-1 infection levels and size of CD4+ T cell subsets. (A, B) Cellular infection levels of patients H434 and H671 for the naïve, CD57−memory and CD57+
memory CD4+ Tcell subsets are depicted on the left y-axis in number of gag copies per 105 cells as determined by qPCR. Serumviral load values are depicted in the same graph on the right
y-axis. Time-points after coreceptor switch aremarkedwith an asterisk. (C, D) Longitudinal overviewof absolute CD4+ subset cell numbers inperipheral blood for patientsH434 andH671.
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talization. One explanation could be the short lifespan of HIV-1
infected cells. Since the half-life of productively infected cells is
estimated to be 1.6 days, the majority of infected cells we analyze are
recently infected although we cannot exclude the presence of minor
quasispecies in these peripheral blood subsets (Perelson et al., 1996).
The main difference with the study from Delobel et al. is that there is
ongoing viral replication in our patients, while their study contains
three patients who were receiving seven years of HAART (Delobel et
al., 2005). The predominant African origin of our study population
might also explain comparable subset distribution of the viral
quasispecies. Increased immune activation among Africans compared
to Europeans might promote viral replication and diversity and
thereby reducing viral compartmentalization (Messele et al., 1999;
Kemp et al., 2001; Llewellyn et al., 2006). The presence of
compartmentalization at some time-points of patient M12817 might
be explained by the patient's altered immune response, since viral
diversity has been shown to partly coincide with selective immune
pressure (Borrow et al., 1997; Wolinsky et al., 1996). The cellular
infection levels of this patient are somewhat lower than seenwith the
other patients.
We observed high variation in HIV-1 infection levels of the
different CD4+ T cell populations. In lymphoid tissues, where a large
part of viral replication is believed to occur, the CD57−memory subset
is the most prevalent CD4+ T cell subset, which may help explain its
preferential targeting (Yang et al., 2005). Our data demonstrates more
variation in infection levels than previously described (Brenchley
et al., 2004a). An explanation for the patients showing predominant
infection of naïve or effector memory cells might be that they were in
a later stage of disease or had heightened immune activation at that
time-point. The average viral load value of our patient group was
twice as high as compared to the group in the previous study, where
nearly half of the patients were receiving HAART. Differences could
also reﬂect the subtype differences and/or the African origin of ourpatients, since individuals from certain African populations have been
shown to harbor increased immune activation in comparison to
Europeans (Kemp et al., 2001; Messele et al., 1999).
Infection of the naïve CD4+ T cell subset was detected in all
patients, even after 0.2 mpsc in the case of patient H671, and this
patient was infected with CCR5 using isolates early in infection (Geels
et al., 2006). Previous ﬁndings have shown that viruses with a lower
V3 charge are likely to possess higher CCR5 afﬁnity, facilitating
infection of the naïve subset where CCR5 expression levels are low
(Nabatov et al., 2004). However, we cannot rule out that other enve-
lope modiﬁcations can compensate for such charge variations. The
observation that naïve CD4+ T cell infection is not restricted to
X4-using viruses has previously been shown (Ostrowski et al., 1999).
Surprisingly, patients M12228 and M12020 harbored a substantial
naïve infection level with M12228 having predominant +4 charged
V3 regions. Subset infection levels did not correlate with viral
diversity, only if all subsets were grouped and compared to syno-
nymous distances (rs=0.38; pb0.005). This is in line with the
ﬁndings of Lemey et al. where synonymous substitution rates predict
HIV-1 disease progression (Lemey et al., 2007).
For patients H671 and H434 infection levels of all CD4+ T cell
subsets increased comparably over time, except for the effector
memory subset of H671, followed by a decrease in naïve and central
memory cell numbers. The constant effector memory cell numbers
likely reﬂect the minor inﬂuence of viral infection on the lifespan of
this already short-lived cell type. Upon viral coreceptor switch in
patient H671 the naïve subset showed a 69-fold increase in infection
levels, which corresponds with previous literature (Blaak et al., 2000).
Initially, naïve cell numbers may have remained high due to either
homeostatic mechanisms or low pathogenicity of the dual-tropic viral
variants. Disappearance of higher charged viruses and a reduction in
predicted X4 variants within this subset between 69 and 89 mpsc
support this explanation (data not shown). At 89 mpsc the more
pronounced destruction of the naïve subset compared to the relatively
Fig. 6. Longitudinal overview of the net env V3 charge distribution of HIV-1 variants isolated from different CD4+ T cell compartments of patients H671 (A) and H434 (B). The relative quantity of the viruses within the naïve, CD57−memory,
CD57+ memory and serum subsets and of the RCBCs is depicted on the y-axis and the net V3 charge is depicted on the x-axis. Time of sampling in months post seroconversion (mpsc) and the number of env variants analyzed are indicated
above each panel. The CD57+ memory subset of 0.2 and 89 mpsc of patient H671 contains V3 clones from hyper-mutated viral variants, as indicated by asterisks.
29
E.J.H
eeregrave
et
al./
V
irology
393
(2009)
24
–32
30 E.J. Heeregrave et al. / Virology 393 (2009) 24–32more preserved central memory subset could be partly explained by
higher infection levels of the naïve population (11,445 vs. 1066 gag
copies per 105 cells). Another explanation may be that dual-tropic
viruses more likely enter the naïve subset using CXCR4 and thereby
induce more cell death, while R5-mediated entry of the memory
subsets do not readily kill these cells (Zhou et al., 2008). Alternatively,
homeostatic mechanisms may fail over time and/or there is increased
differentiation into a more effector (memory) phenotype. To predict
absolute levels of viral production by the various subsets, we com-
bined infection levels with subset cell numbers. The central memory
cells were the major producing subset, even after H671 switched viral
coreceptor usage. However, these numbers remain predictions since
we did not directly determine production levels, which will likely
differ between the subsets.
In Fig. 6 we observed comparable V3 charge distribution among
all subsets, including serum, with no evidence of target cell selection,
except for 69 mpsc of patient H671. Higher charged (and predicted
X4 phenotype) viruses were infecting naïve and central memory
cells, whereas lower charged variants were found within the effector
memory subset. This distribution did not result in viral compart-
mentalization, since all subsets contained both R5 and X4 using
variants (unpublished data). A different ratio of coreceptor expres-
sion may explain this temporal preferential attraction of higher
charged variants (Groot et al., 2006). At 89 mpsc the viral quasi-
species in the naïve and central memory subset reduced its V3 charge
and we observed a comparable charge distribution among all subsets.
The low number of X4-using clones (1/13 or 7.7%) and low number of
higher charged variants in the serum at 69 mpsc indicate that these
variants might not have been ﬁt enough to persist. In other words,
patient H671 demonstrated the same viral evolution pattern upon
coreceptor switch despite the preferential viral propagation in the
naïve subset. One explanation can be that the dual-tropic variants
infect all CD4+ T cell subsets, including the memory cells. In addition,
all subsets including the naïve population likely remain infected with
R5 variants. These cells remain present upon coreceptor switch and
have been described by some groups to be more capable of
producing infectious virions compared to X4-using variants (Singh
and Collman, 2000; Roy et al., 2005; Verhofstede et al., 2009). Our
data from patient H434 indicates that also in a non-switching patient
naïve infection levels increase over time. We must keep in mind,
however, that we base these conclusions on ﬁndings from a single
individual.
In summary, we demonstrate that HIV-1 evolution within naïve
and memory CD4+ T cell subsets is comparable. Although there is
variation in infection levels, we ﬁnd no evidence of compartmenta-
lization among naïve, central and effector memory CD4+ T cells.
Despite the more pronounced changes of the naïve subset upon
coreceptor switch, we observe comparable virus evolution among
all studied subsets. These ﬁndings emphasize the importance of all
CD4+ T cell subsets to viral evolution and disease pathogenesis.
Materials and methods
Patient characteristics and viral characterization
Thirteen HIV-1 positive individuals were included in this study, of
which eleven regularly visited the outpatient clinic of the Academic
Medical Center, the Netherlands. Two well-characterized patients
(H671 and H434) were included from the Amsterdam Cohort Studies
(ACS) on HIV-1 infection and AIDS for more extensive follow-up. The
individuals demonstrate large variation in viral load values and CD4+
T cell counts and harbor viruses representing six different HIV-1
subtypes, being A, B, C, D, F and G (Table 1).
HIV-1 genotyping was performed utilizing phylogenetic analysis
(Neighbor-Joining method) of the env C2V3 region with a set of
reference sequences from the Los Alamos database (http://www.hiv.lanl.gov). Viral loads were determined using the branch DNA assay. All
patients were in their chronic phase of HIV-1 infection. The study was
approved by the Medical Ethical Committee, Academic Medical
Center, University of Amsterdam.
The clinical proﬁles of H671 and H434 have been previously
described (Geels et al., 2003, 2006). Replication competent biological
clones (RCBCs)were isolated from peripheral bloodmononuclear cells
(PBMC) isolated at different time-points during infection by limiting
dilution (Koot et al., 1996; Geels et al., 2003, 2006). The SI phenotype
was determined utilizing the MT2 cell-line assay. Characterization of
HIV-1 coreceptor usage was performed on the U87 astroglioma cell-
line stably transfected with CD4 and either CCR1, CCR2b, CCR3, CXCR4,
or CCR5 as well as on CD4-enriched PBMC isolated from Δ32 CCR5
homozygous individuals (de Roda Husman et al., 1999; Liu et al.,
1996).Polychromatic leukocyte cell sorting
PBMC were thawed and washed with RPMI 1640 medium,
supplemented with 10% heat-inactivated fetal calf serum, 100 U of
penicillin, 100 μg of streptomycin and 1.7 mM sodium glutamate.
Cells were subsequently stained with the appropriate monoclonal
antibodies for 30 min and ﬁxed with 1% paraformaldehyde. Three
CD4+ T cell subsets were sorted: naïve, CD57− memory (or central
memory) and CD57+ memory (or effector memory) CD4+ T cells,
with CD57 being a marker for replicative senescence and terminal
differentiation (Palmer et al., 2005; Brenchley et al., 2003). We
measured and separated the CD4+ cells with αCD3-FITC, αCD4-
Alexa 594, αCD8-Cy7-PE, αCD11a-APC, αCD14-Cy5-PE, αCD19-Cy5-
PE, αCD27-PE, αCD45RO-Texas Red-PE, αCD56-Cy5-PE and αCD57-
Cas (BD Pharmingen). All cell sorts were performed utilizing a
modiﬁed FACS DIVA and the strategy for leukocyte population
sorting is graphed in supplemental data I. Post-sort analysis showed
over 98% purity of the sorted cell populations. Sorted fractions were
stored at −80 °C.HIV-1 DNA quantiﬁcation
Quantiﬁcation of cell-associated HIV-1 DNA for patients H671 and
H434 was previously described (Douek et al., 2002). We quantiﬁed
cellular HIV-1 infection levels of the AMC outpatient clinic samples
using a semi-nested real-time PCR assay allowing for the ampliﬁcation
of all HIV-1 subtypes. This assay ampliﬁes the HIV-1 long terminal
repeat (LTR) region and ampliﬁes full-length genomes. Viral DNA
underwent 15 cycles of pre-ampliﬁcation using AmpliTaq DNA
polymerase. The forward primer was LTRPREGP (5′-TAACCCTCA-
GATGCTGCATAwAAGCAGCyGCT-3′) and the reverse primer L-GAGM-
NEW (5′-AGCAAGCCGAGTCCTGCGTC-3′). The cycling conditions were
as follows: 5 min 95 °C followed by 15 cycles of (1 min 95 °C – 1 min
55 °C – 2 min 72 °C) and 10 min 72 °C. The product was used as
template in the TaqMan quantiﬁcation step, which was performed
using 2× Platinum quantitative PCR Super mix UDG (Invitrogen),
2.5 mM MgCl2, 0.5 μM Rox reference dye, 0.9 μM of each primer
and 0.19 μM of the TaqMan dual-labeled ﬂuorescent probe (PGPLTR
5′-GTADCTAGAGATCCCTCAGAC-3′. Primer sequences were FGPLTR1
(5′-GCCTCAATAAAGCTTGCCTTGA-3′) and RPGLTR1 (5′-GGGCGCCAC-
TGCTAGAGAT-3′). The cycling conditions were as follows: 2 min
50 °C, 10 min 95 °C, followed by 45 cycles of (15 s 95 °C – 1 min
60 °C). Plasmid DNA corresponding to the region of interest was
used as an external standard. To determine cellular input, a β-
actin gene standard curve was constructed and run in parallel.
Reactions were performed in duplicate and samples where diffe-
rences between the duplicates exceeded 0.5 log were not in-
cluded. Results were analyzed using the ABI Prism 7700 Software.
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Viral DNA from the cellular subsets was isolated utilizing a silica-
based method, which was also used for RNA isolation from serum
(Boom et al., 1990). For patients H671 and H434 the env C1C4 region
of the RNA was reverse transcribed using avian myeloblastosis virus
reverse transcriptase (AMV-RT) as described previously with slight
modiﬁcations (Cornelissen et al., 1997). The cDNAs and sorted
leukocyte lysates (containing viral DNA) were used in the Expand
Long Template PCR system. The volume of the added cell lysate
corresponded to 100–500 gag copies as determined by quantitative
PCR (qPCR) as published (Douek et al., 2002; Brenchley et al., 2004a).
For the AMC outpatient samples the C2V3 env region (HXB2 positions
7032–7301) were PCR ampliﬁed with AMV-RT used for reverse
transcription of the serum-derived RNA. For the ﬁrst PCR the following
primers were used: 5′-AATGTCAGCACAGTACAATG-3′ and 3′-TCTCCT-
CCTCCAGGYCTGAA-5′. Subsequently, a nested PCR using the primers
5′-CCAGTGGTATCAACTCAA-3′ and 3′-ATTTCTAAGTCCCCTCCTGA-5′
was performed (100 ng/μl). Inter-patient cross-contamination was
ruled out using bootstrapped maximum likelihood phylogenetic
analysis (data not shown).HIV-1 sequencing and sequence analysis
Positive PCR products were cloned into the TOPO II vector and
bacterial colonies were selected using ampicillin. Positive colonies
were sequenced bi-directionally using the BigDye Terminator Cycle
Sequencing kit and analyzed using an ABI 377 automated sequencer.
Six to twenty-six clones for each subset were sequenced. Quality of
the sequences was analyzed using CodonCode Aligner version 1.5.1,
after which these were automatically aligned with BioEdit 7.0.1. Using
Textpad 4.5.0 the sequences were manually adjusted with respect to
the gp120 open reading frame according to reference sequences from
the Los Alamos HIV sequence database (http://www.hiv.lanl.gov).
Phylogenetic and molecular evolutionary analyses were conducted
using MEGA version 4 (Tamura et al., 2007). Statistical analyses
utilized the Wilcoxon signed rank test with correlation coefﬁcients
computed by Graphpad Prism 5.01 using the nonparametric Spear-
man correlation. Sequences containing stop codons were not
included in the analyses. The predicted coreceptor usage of subtype
B and C virus sequences was determined using a web-based position-
speciﬁc scoring matrix (PSSM), available at http://ubik.microbiol.
washington.edu/computing/pssm. Serum sequences described in this
study were allocated Genbank accession numbers GQ389219-
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